|
Books > Medicine > General issues > Public health & preventive medicine
|
Not currently available
Making Medicines Affordable - A National Imperative (Paperback)
Loot Price: R1,511
Discovery Miles 15 110
|
|
|
Making Medicines Affordable - A National Imperative (Paperback)
Supplier out of stock. If you add this item to your wish list we will let you know when it becomes available.
|
Thanks to remarkable advances in modern health care attributable to
science, engineering, and medicine, it is now possible to cure or
manage illnesses that were long deemed untreatable. At the same
time, however, the United States is facing the vexing challenge of
a seemingly uncontrolled rise in the cost of health care. Total
medical expenditures are rapidly approaching 20 percent of the
gross domestic product and are crowding out other priorities of
national importance. The use of increasingly expensive prescription
drugs is a significant part of this problem, making the cost of
biopharmaceuticals a serious national concern with broad political
implications. Especially with the highly visible and very large
price increases for prescription drugs that have occurred in recent
years, finding a way to make prescription medicines?and health care
at large?more affordable for everyone has become a socioeconomic
imperative. Affordability is a complex function of factors,
including not just the prices of the drugs themselves, but also the
details of an individual's insurance coverage and the number of
medical conditions that an individual or family confronts.
Therefore, any solution to the affordability issue will require
considering all of these factors together. The current high and
increasing costs of prescription drugs?coupled with the broader
trends in overall health care costs?is unsustainable to society as
a whole. Making Medicines Affordable examines patient access to
affordable and effective therapies, with emphasis on drug pricing,
inflation in the cost of drugs, and insurance design. This report
explores structural and policy factors influencing drug pricing,
drug access programs, the emerging role of comparative
effectiveness assessments in payment policies, changing finances of
medical practice with regard to drug costs and reimbursement, and
measures to prevent drug shortages and foster continued innovation
in drug development. It makes recommendations for policy actions
that could address drug price trends, improve patient access to
affordable and effective treatments, and encourage innovations that
address significant needs in health care. Table of Contents Front
Matter Summary 1 The Affordability Conundrum 2 Complexity in Action
3 Factors Influencing Affordability 4 Strategies to Improve
Affordability and Availability References Appendix A: A Dissenting
View - Michael Rosenblatt and Henri Termeer Appendix B: A Minority
Perspective - Rena Conti, Stacie Dusetzina, Martha Gaines,Rebekah
Gee, Victoria Hale, Peter Sands, and Alan Weil Appendix C: Glossary
Appendix D: Stakeholder Input Appendix E: Biographical Information
Appendix F: Disclosure of Conflicts of Interest
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
You might also like..
|
Welcome to Loot.co.za!
Sign in / Register |Wishlists & Gift Vouchers |Help | Advanced search
(4)
(1)
